Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: Studies in apolipoprotein E knockout mice

Circulation

Volumn 96, Issue 8, 1997, Pages 2722-2728

  Shi, Chengwei ^a   Lee, Wen Sen ^a,b   Russell, Mary E ^a,b,c   Zhang, Dorothy ^a   Fletcher Jr , Donald L ^a   Newell, John B ^d   Haber, Edgar ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Hypercholesterolemia; Muscle, smooth; Transplantation; Vasculature

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART TRANSPLANTATION; HYPERCHOLESTEROLEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SMOOTH MUSCLE FIBER;

EID: 0030824421     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2722     Document Type: Article

References (29)

1. Sarris GE, Moore KA, Schroeder JS, Hunt SA, Fowler MB, Valantine HB, Vagelos RH, Billingham ME, Oyer PE, Stinson EB, Reitz BA, Shumway NE. Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg. 1994; 108:240-251.
2. Eich D, Thompson JA, Ko DJ, Hastillo A, Lower R, Katz S, Katz M, Hess ML. Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transplant. 1991;10:45-49.
3. Sharples LD, Caine N, Mullins P, Scott JP, Solis E, English TA, Large SR, Schofield PM, Wallwork J. Risk factor analysis for the major hazards following heart transplantation: rejection, infection, and coronary occlusive disease. Transplantation. 1991;52:244-252.
4. Gao SZ, Schroeder JS, Hunt S, Stinson EB. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol. 1988;62:876-881.
5. Winters GL, Kendall TJ, Radio SJ, Wilson JE, Costanzo-Nordin MR, Switzer BL, Remmenga JA, McManus BM. Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Transplant. 1990;9:364-371.
6. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA, Trosian K, Hamilton MA, Moriguchi JD, Kawata N, Hage A, Drinkwater DC, Stevenson LW. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333:621-627.
7. Tanaka H, Sukhova GK, Libby P. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb. 1994;14:734-745.
8. Alonso DR, Starek PK, Minick CR. Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol. 1977;87:415-442.
9. Mennander A, Tikkanen MJ, Räisänen-Sokolowski A, Paavonen T, Ustinov J, Hayry P. Chronic rejection in rat aortic allografts, IV: effect of hypercholesterolemia in allograft arteriosclerosis. J Heart Lung Transplant. 1993;12:123-132.
10. Adams DH, Karnovsky MJ. Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts. Transplant Proc. 1989;21:437-439.
11. Russell PS, Chase CM, Colvin RB. Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients. Am J Pathol. 1996;149:91-99.
12. Shi C, Russell ME, Bianchi C, Newell JB, Haber E. Murine model of accelerated transplant arteriosclerosis. Circ Res. 1994;75: 199-207.
13. Shi C, Lee WS, He Q, Zhang D, Fletcher DL Jr, Newell JB, Haber E. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A. 1996;93:4051-4056.
14. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A. 1992;89:4471-4475.
15. Plump AS, Smith JD, Hayek T, Aalto SK, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
16. Dixon WJ, ed. BMDP Program 4V, Release 7. Berkeley, Calif: University of California Press; 1992:1259-1310.
17. Morrison DF. Multivariate Statistical Methods. New York, NY: McGraw-Hill Book Co; 1976:32-34.
18. Dixon WJ, ed. BMDP Program 2R, Release 7. Berkeley, Calif: University of California Press; 1992:387-425.
19. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
20. Kocher O, Gabbiani G. Expression of actin mRNAs in rat aortic smooth muscle cells during development, experimental intimal thickening, and culture. Differentiation. 1986;32:245-251.
21. Owens GK, Loeb A, Gordon D, Thompson MM. Expression of smooth muscle-specific α-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol. 1986;102:343-352.
22. Langillc BL. Remodeling of developing and mature arteries: endothelium, smooth muscle, and matrix. J Cardiovasc Pharmacol. 1993; 21(suppl 1):S11-S17.
23. Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billingham ME. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant. 1989;8:349-359.
24. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem. 1996;271:8837-8842.
25. Yue TL, Wang X, Sung CP, Olson B, McKenna PJ, Gu JL, Feuerstein GZ. Interleukin-8: a mitogen and chemoattractant for vascular smooth muscle cells. Circ Res. 1994;75:1-7.
26. Bozic CR, Gerard NP, von Uexkull-Guldenband C, Kolakowski LF Jr, Conklyn MJ, Breslow R, Showell HJ, Gerard C. The murine interleukin 8 type B receptor homologue and its ligands: expression and biological characterization. J Biol Chem. 1994;269:29355-29358.
27. Heinrich JN, Bravo R. The orphan mouse receptor interleukin (IL)-8Rβ binds N51: structure-function analysis using N51/IL-8 chimeric molecules. J Biol Chem. 1995;270:4987-4989.
28. 125I-interleukin (IL)-8 binding to IL-8Rβ but not IL-8Rα: structure-function analysis using N51/IL-8 chimeric molecules. J Biol Chem. 1995;270:28014-28017.
29. Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med. 1992;43:219-225.